(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery...
Stats | |
---|---|
आज की मात्रा | 852.00 |
औसत मात्रा | 934.00 |
बाजार मूल्य | 9.60B |
EPS | $1.030 ( 2023-06-30 ) |
Last Dividend | $1.174 ( 2023-03-23 ) |
Next Dividend | $0 ( N/A ) |
P/E | 32.33 |
ATR14 | $0.276 (0.26%) |
Carl Zeiss Meditec AG सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Carl Zeiss Meditec AG वित्तीय
Annual | 2023 |
राजस्व: | $2.09B |
सकल लाभ: | $1.21B (57.71 %) |
EPS: | $3.25 |
FY | 2023 |
राजस्व: | $2.09B |
सकल लाभ: | $1.21B (57.71 %) |
EPS: | $3.25 |
FY | 2022 |
राजस्व: | $1.90B |
सकल लाभ: | $1.13B (59.26 %) |
EPS: | $3.29 |
FY | 2021 |
राजस्व: | $1.65B |
सकल लाभ: | $967.21M (58.73 %) |
EPS: | $2.64 |
Financial Reports:
No articles found.
Carl Zeiss Meditec AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$1.174 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.527 | 2013-03-01 |
Last Dividend | $1.174 | 2023-03-23 |
Next Dividend | $0 | N/A |
Payout Date | 2023-04-11 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | $7.38 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.86 | -- |
Div. Sustainability Score | 3.69 | |
Div.Growth Potential Score | 4.66 | |
Div. Directional Score | 4.17 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TEZNY | Ex Dividend Junior | 2023-06-16 | Semi-Annually | 0 | 0.00% | |
HWDJY | Ex Dividend Knight | 2023-10-12 | Annually | 0 | 0.00% | |
BASFY | Ex Dividend Knight | 2023-05-01 | Annually | 0 | 0.00% | |
PFLC | Ex Dividend Knight | 2023-08-10 | Quarterly | 0 | 0.00% | |
EBKDY | Ex Dividend Junior | 2023-05-16 | Annually | 0 | 0.00% | |
UELMO | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
JUMSF | Ex Dividend Knight | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
BTSDF | No Dividend Player | 2023-09-05 | Annually | 0 | 0.00% | |
RSTRF | Ex Dividend Knight | 2023-09-19 | Semi-Annually | 0 | 0.00% | |
FFWC | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.132 | 1.500 | 7.36 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.134 | 1.500 | 9.62 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 24.02 | 1.000 | 2.22 | 2.22 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.33 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.573 | 1.000 | 3.78 | 3.78 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.196 | 1.000 | 8.08 | 8.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 32.28 | 1.000 | 6.84 | 0 | [1 - 100] |
returnOnEquityTTM | 0.134 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.55 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.189 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -28.41 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.112 | 1.000 | 9.71 | 0 | [0.1 - 0.5] |
Total Score | 4.66 |
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं